doi: 10.1016/s1359-6446(99)01373-2.
Visual exploration of HTS databases: bridging the gap between chemistry and biology
Affiliations
- PMID: 10431147
- DOI: 10.1016/s1359-6446(99)01373-2
Item in Clipboard
Visual exploration of HTS databases: bridging the gap between chemistry and biology
Drug Discov Today.
1999 Aug.
Abstract
As pharmaceutical corporations are under pressure to shorten research and development (R&D) cycles for new drugs, novel technologies are being deployed, producing a data explosion in the research environment. Researchers can then become the bottleneck in the R&D cycle when they are unable to analyze data quickly enough. To deliver on the promise of these high-throughput technologies, pharmaceutical R&D must introduce novel decision support systems to support the mantra of R&D decision support: access, analyze and publish.
Similar articles
-
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development.Altern Lab Anim. 2000 Nov-Dec;28(6):857-67. doi: 10.1177/026119290002800602. Altern Lab Anim. 2000. PMID: 11105205 Review.
-
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development.Toxicol Lett. 2002 Feb 28;127(1-3):143-51. doi: 10.1016/s0378-4274(01)00494-5. Toxicol Lett. 2002. PMID: 12052652 Review.
-
Systems Biology Applications to Decipher Mechanisms and Novel Biomarkers in CNS Trauma.In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 30. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 30. PMID: 26269919 Free Books & Documents. Review.
-
Building a disease knowledge environment to lay the foundations for in silico drug discovery and translational medicine.Expert Opin Drug Discov. 2010 Feb;5(2):117-22. doi: 10.1517/17460440903548226. Epub 2010 Jan 11. Expert Opin Drug Discov. 2010. PMID: 22822911
-
Alternative strategies in drug development: clinical pharmacological aspects.Int J Clin Pharmacol Ther. 1999 Dec;37(12):575-83. Int J Clin Pharmacol Ther. 1999. PMID: 10599949 Review.
Cited by
-
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.Br J Pharmacol. 2007 Sep;152(1):9-20. doi: 10.1038/sj.bjp.0707305. Epub 2007 Jun 4. Br J Pharmacol. 2007. PMID: 17549047 Free PMC article. Review.
-
Bottlenecks caused by software gaps in miRNA and RNAi research.Pharm Res. 2012 Jul;29(7):1717-21. doi: 10.1007/s11095-012-0712-x. Epub 2012 Feb 24. Pharm Res. 2012. PMID: 22362409
-
Extracting SAR Information from a Large Collection of Anti-Malarial Screening Hits by NSG-SPT Analysis.ACS Med Chem Lett. 2011 Jan 5;2(3):201-6. doi: 10.1021/ml100240z. eCollection 2011 Mar 10. ACS Med Chem Lett. 2011. PMID: 24900303 Free PMC article.
-
New strategies in drug discovery.Methods Mol Biol. 2006;316:1-11. doi: 10.1385/1-59259-964-8:1. Methods Mol Biol. 2006. PMID: 16671397 Free PMC article. Review.
-
ADAAPT: Amgen's data access, analysis, and prediction tools.J Comput Aided Mol Des. 2006 Apr;20(4):249-61. doi: 10.1007/s10822-006-9048-0. Epub 2006 Jun 21. J Comput Aided Mol Des. 2006. PMID: 16897579
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
